subject: Chinese medicine related to "makeup" to accelerate transition of new medicine on the adjustment of product line - of new drugs - the [print this page] Chinese medicine related to "makeup" to accelerate transition of new medicine on the adjustment of product line - of new drugs - the
Recently, Shanghai, China Pharmaceutical Company Limited (Chinese medicine), "Shu Sing" series of products covered in the first one Fahrenheit large pharmacy products, which means that Chinese medicine has taken the pace of transformation.
It is the first large-scale attack Chinese medicine non-functional Drugs Area, its main channel would be pharmacy, rather than supermarkets. Among them, the F major pharmacy distribution center Limited (Fahrenheit) will become the total Proxy , The major chain pharmacies as distribution company.
Select pharmacies and not supermarkets as Sell Channels, some analysts believe that Chinese medicine with the existing talent, the team has a tradition of characteristics and advantages of the OTC channels. Chinese medicine and pharmacy chains Fahrenheit and Fahrenheit are the drug companies in the Group after the Pharmaceutical Group chairman has repeatedly said Lu Ming Fang Pharmaceutical Group to play on the advantages of business collaboration, This time "brother" between Cooperation Naturally seamless.
"Shu Sing" series of products to market launch marked the transformation of Chinese medicine, is also a group of new medicines into new areas of business start.
Previously, Chinese medicine products are New Park, Dragon Tiger Balm brand and the Dragon and Tiger Dan, are mainly OTC products. Recently, the Chinese medicine treatment of drug firm closed a production plant, because generic drugs are not the advantages of Chinese medicine, "development of competitive products and fields must be resolutely shrink the shrink."
As a new medicine on the first group formed to restore corporate enterprises, Chinese medicine can change the face of market independent decision-making, to find the most suitable development path and model, which is its ability to achieve an important prerequisite for transformation.
"Although Chinese medicine in the share of new drugs is very small body, but it is brand extension, the extension of the field." Kuo-Hsiung Shu a new president, told reporters on the medicines listed Johnson Examples of the company, Johnson & Johnson 2009 sales of 61.9 billion U.S. dollars, its Traditional Chinese medicine Product sales accounting for about 1 / 3 of health products sales ratio of 2 / 3. "The new medicines on the Pharmaceutical Group, in addition, business should be involved in the health industry, including cosmetics and pharmaceuticals, Health Products This may lead to new growth. "
Journalists understand that the group is developing a new medicine on coenzyme Q10 and micro-ecological health products.
Addition to changes in business, Chinese medicine sales model will also change.
Press office from Director of Sales Ma Hua learned, according to Chinese medicine's development strategy will be to streamline its sales channels, sales model will become a business distribution model, while for the two distributors, will be screened , is quality rather than quantity. At the same time, will be focused on quality customer support, attention will also benefit from the change in the number of commercial shipments of purchase.
Prior to this, a new medicine on the new leadership group members and the public the meeting, said Lu Ming Fang, in the three-year tenure, the team's assessment indicator is a compound growth rate of after-tax profit of not less than 20%. The drug in the early restructuring of financial accounting, the quality of Chinese medicine are considered assets of the Group, clearly it needs more than 20% growth target.
"Flat old products, new product development round." Military said Chen, the Chinese medicine this year's goal is to increase 22%.
However, relying on makeup and famous, "Shu Sing" in pharmacy sales channels to achieve the above objectives, the Chinese medicine industry in terms of the challenge is great. Earlier this year, the reporter visited Shanghai many pharmacies understand that the current makeup of the overall drug sales is not optimistic. In a familiar network of drug and cosmetic sales not quite familiar, challenge has just begun.
